(2025). Pulsed Electromagnetic Field Therapy in The Treatment of Charcot Foot Ulcer: A Narrative Review. The Egyptian Journal of Hospital Medicine, 99(1), 2424-2426. doi: 10.21608/ejhm.2025.435012
. "Pulsed Electromagnetic Field Therapy in The Treatment of Charcot Foot Ulcer: A Narrative Review". The Egyptian Journal of Hospital Medicine, 99, 1, 2025, 2424-2426. doi: 10.21608/ejhm.2025.435012
(2025). 'Pulsed Electromagnetic Field Therapy in The Treatment of Charcot Foot Ulcer: A Narrative Review', The Egyptian Journal of Hospital Medicine, 99(1), pp. 2424-2426. doi: 10.21608/ejhm.2025.435012
Pulsed Electromagnetic Field Therapy in The Treatment of Charcot Foot Ulcer: A Narrative Review. The Egyptian Journal of Hospital Medicine, 2025; 99(1): 2424-2426. doi: 10.21608/ejhm.2025.435012
Pulsed Electromagnetic Field Therapy in The Treatment of Charcot Foot Ulcer: A Narrative Review
Background: Charcot’s foot ulcer is a severe complication commonly seen in individuals with diabetic neuropathy. This condition is characterized by progressive musculoskeletal deformities, which can lead to ulceration, infection, and, in extreme cases, amputation. Conventional treatments often face limitations in promoting effective wound healing. Pulsed Electromagnetic Field (PEMF) therapy has emerged as a promising non-invasive approach that leverages low-frequency electromagnetic waves to stimulate biological processes critical for tissue regeneration. Objective: This narrative review explores the pathophysiology of Charcot’s foot ulcers, the underlying mechanisms of PEMF therapy, and its application in wound management. Methods: We searched PubMed, Google Scholar, and Science Direct for Charcot foot ulcer, Pulsed electromagnetic field therapy, Diabetic neuropathy, Wound healing and Non-invasive treatment. Only the most recent or thorough investigation, from 2000 to 2025, was taken into account. The writers evaluated relevant literature references as well. Documents written in languages other than English have been ignored. Papers that were not regarded as significant scientific research included dissertations, oral presentations, conference abstracts, and unpublished manuscripts were excluded. Conclusion: The primary therapeutic effects of PEMF include enhanced microcirculation, reduced inflammation, accelerated ATP production, and improved collagen synthesis—all essential components of wound healing. Clinical studies and case reports have demonstrated that PEMF therapy, when used adjunctively with standard care, significantly reduced ulcer size, improved healing rates, and shortened recovery time. Patients also reported diminished pain and improved functional outcomes. The review highlights that PEMF therapy’s benefits are not only physiological but also extend to enhancing patients’ quality of life. Despite its promise, further large-scale, randomized clinical trials are warranted to establish standardized treatment protocols and to fully integrate PEMF therapy into routine clinical practice. This review aimed to contribute to the growing body of evidence supporting PEMF therapy as a valuable tool in the multidisciplinary management of Charcot’s foot ulcers.